| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992232 | Journal of Thoracic Oncology | 2007 | 8 Pages |
Abstract
Lung cancer is the leading worldwide source of cancer-related death. It is acknowledged that prognosis and treatment outcomes in lung cancer might be improved by increasing the effectiveness of early-stage diagnosis. Several recently published studies have produced intriguing results regarding the detection of biomarkers in tumor samples, but also in easily accessible specimens such as sputum, plasma, and exhaled breath condensate. This review presents advances in genetic diagnostics of lung cancer, with particular reference to the clinical usefulness of individual biomarkers, specimens, and methods. The adequacy of their sensitivity and specificity for cancer screening and early detection is discussed in detail.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Joanna Chorostowska-Wynimko, Adam Szpechcinski,